Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma Of Esophagus × trastuzumab biosimilar HLX02 × 30 days × Clear all

Sponsor

Conditions

Malignant Solid Neoplasm 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1 Advanced Breast Carcinoma 1

Interventions

Fluorouracil 9 Oxaliplatin 8 Nivolumab 8 Leucovorin 7 Capecitabine 7 pembrolizumab 3 Trastuzumab 3 Specimen Handling 3 Paclitaxel 3 Cisplatin 3 zimberelimab 2 zanidatamab 2 dehydroftorafur 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Docetaxel 2 Biopsy 2 zolbetuximab 1 tucatinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 toripalimab 1 tislelizumab 1 quemliclustat 1 obeticholic acid 1 durvalumab 1 Taxes 1 Ramucirumab 1 Radiotherapy 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡